NovaTechs BV is a private company located at the Brightlands Chemlot Campus in Sittard-Geleen, Netherlands. Founded in 2020 by a team of researchers with expertise in drug delivery technologies, including nano-pharmaceuticals and polymeric hydrogels, the company is working on liquid embolic systems for minimally invasive blood vessel occlusion.
The first application of this technology, NovaSeal™, is a hydrogel-based solution designed to address key challenges in treating hypervascular tumors in cancer patients.
Novatechs has funding through LIOF and Rabobank.
